Valuation: SMAIO

Market Cap 48.33M 55.24M 44.57M 41.23M 78.26M 5.27B 79.57M 534M 209M 2.59B 207M 203M 8.97B P/E 2026 *
-24.9x
P/E 2027 * 123x
Enterprise Value 46.23M 52.84M 42.63M 39.44M 74.86M 5.04B 76.12M 511M 200M 2.48B 198M 194M 8.58B EV / Sales 2026 *
3.85x
EV / Sales 2027 * 2.8x
Free-Float
29.17%
Yield 2026 *
-
Yield 2027 * -
1 day-0.23%
1 week+3.37%
Current month+10.57%
1 month+6.45%
3 months+18.51%
6 months+30.99%
Current year+37.28%
1 week 8.28
Extreme 8.28
8.94
1 month 7.44
Extreme 7.44
8.94
Current year 6
Extreme 6
9.1
1 year 5.5
Extreme 5.5
9.1
3 years 2.14
Extreme 2.14
9.1
5 years 1.9
Extreme 1.9
9.1
10 years 1.9
Extreme 1.9
9.1
Manager TitleAgeSince
Chief Executive Officer - 28/12/2008
Director of Finance/CFO - 31/05/2022
Chief Tech/Sci/R&D Officer - 30/06/2020
Director TitleAgeSince
Chairman - 29/07/2021
Change 5-day change 1-year change 3-year change Capi.($)
-0.23%+3.37%+54.59%+260.50% 55.24M
+0.09%+0.25%+54.65%+169.19% 1,085B
-1.63%-1.50%+65.79%+62.70% 624B
-1.12%-4.27%+31.10%+84.44% 442B
+0.18%-1.76%+29.04%+26.51% 332B
-6.22%-8.14%+28.87%+32.09% 277B
-1.27%-2.91%+27.42%+46.39% 282B
-0.93%-3.57%-27.74%-40.38% 217B
-1.19%-2.81%+22.63%+66.30% 196B
-0.72%+2.72%+19.07%+81.19% 167B
Average -1.17%-1.34%+30.54%+78.89% 362.2B
Weighted average by Cap. -0.88%-1.06%+38.95%+85.21%

Financials

2026 *2027 *
Net sales 11.99M 13.71M 11.06M 10.23M 19.42M 1.31B 19.75M 132M 51.92M 643M 51.47M 50.35M 2.23B 16.76M 19.16M 15.45M 14.3M 27.14M 1.83B 27.59M 185M 72.55M 898M 71.91M 70.36M 3.11B
Net income -1.67M -1.91M -1.54M -1.43M -2.71M -183M -2.76M -18.48M -7.24M -89.67M -7.18M -7.03M -311M 278K 318K 256K 237K 450K 30.33M 458K 3.07M 1.2M 14.9M 1.19M 1.17M 51.6M
Net Debt -2.1M -2.4M -1.94M -1.79M -3.4M -229M -3.46M -23.19M -9.09M -113M -9.01M -8.82M -390M -1.4M -1.6M -1.29M -1.19M -2.27M -153M -2.31M -15.46M -6.06M -75.01M -6.01M -5.88M -260M
Logo SMAIO
S.M.A.I.O « Software, Machines and Adaptive Implants in Orthopaedics » is specialized in the design, manufacture and marketing of implantable medical devices for the treatment of spinal pathologies. The company offers the Kheiron Spinal Fixation System, a device that incorporates many implants, intended for the immobilization and stabilization of spinal segments as an adjunct to fusion of the thoracic, lumbar and/or sacral spine. In addition, S.M.A.I.O has developed the Keops and Balance Analyzer 3D surgical planning and patient database management software, and the company also offers training programs. Net sales break down by source of revenue between sales of products (98.9%) and services (1.1%). Net sales are distributed geographically as follows: France (9.8%), Europe (12.2%), the United States (76.2%), Oceania (1%), Middle East and Africa (0.7%) and Canada (0.1%).
Employees
45
Date Price Change Volume
09/07/26 €8.580 -0.23% 141
08/07/26 €8.600 -1.15% 2,504
07/07/26 €8.700 +0.23% 3,529
06/07/26 €8.680 +6.37% 5,443
03/07/26 €8.160 -1.69% 366
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
8.580EUR
Average target price
8.250EUR
Spread / Average Target
-3.85%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALSMA Stock